Erasca Inc (ERAS) PT Raised to $24 at Jefferies, 'underappreciated' Jul 14, 2026 03:53PM
H.C. Wainwright Reiterates Buy Rating on Erasca Inc (ERAS) Jul 14, 2026 06:59AM
Erasca, Inc (ERAS) files mixed shelf Jul 13, 2026 04:18PM
Goldman Sachs Starts Erasca Inc (ERAS) at Early-Stage Biotech Jul 13, 2026 05:09AM
Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline Jul 8, 2026 10:13PM
View Older Stories

Jul 7, 2026 03:03PM Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Jul 6, 2026 01:32PM Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Jul 2, 2026 05:42PM Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Jul 1, 2026 05:40PM Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Jun 30, 2026 04:06PM Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Jun 29, 2026 04:04PM Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Jun 25, 2026 03:45PM Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Jun 24, 2026 03:43PM Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Jun 23, 2026 03:34PM Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Jun 22, 2026 02:00PM Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Jun 19, 2026 04:37PM Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Jun 18, 2026 04:36PM Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Jun 17, 2026 04:31PM Erasca, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
Jun 4, 2026 05:13AM BofA Securities Upgrades Erasca Inc (ERAS) to Neutral, 'we see the downside case as now less compelling'
May 12, 2026 05:04AM Erasca Inc (ERAS) PT Lowered to $26 at Mizuho
May 11, 2026 04:31PM Erasca, Inc. (ERAS) Misses Q1 EPS by 49c
May 1, 2026 04:08PM SHAREHOLDER ALERT: Erasca, Inc. Investigated for Securities Fraud Violations by Block & Leviton
Apr 29, 2026 12:22PM Erasca, Inc. ALERT: Securities Fraud Investigation by Block & Leviton Could Allow Investors to Recover Losses
Apr 28, 2026 01:54PM Erasca shares cut in half after patient death in clinical trial
Apr 28, 2026 10:49AM Increasing unusual option volume: ERAS SANM OGN BBBY SNBR PAGS CDNS PII
Apr 28, 2026 06:42AM H.C. Wainwright Reiterates Buy Rating on Erasca Inc (ERAS)
Apr 28, 2026 05:14AM Erasca Inc (ERAS) PT Raised to $9 at BofA Securities
Apr 27, 2026 04:49PM Erasca, Inc (ERAS) releases slides on phase 1 data for RAS cancer drug ERAS-0015
Apr 27, 2026 07:24AM Erasca Inc (ERAS) PT Raised to $30 at Stifel After CEO Chat
Apr 20, 2026 11:06AM Jefferies stays Buy on Erasca Inc (ERAS): ASCO'26 a potential inflection point with Ph1 monotx data presentation likely
Apr 13, 2026 12:00PM Jefferies on Erasca Inc (ERAS): RVMD data leaves bar for ERAS 'unchanged'
Apr 13, 2026 05:52AM Bernstein on US Pharma and Biotech: Who might buy whom?
Mar 13, 2026 07:47AM Erasca (ERAS) Reiterated at Buy by Stifel After Q4 Results
Mar 13, 2026 06:43AM Erasca Inc (ERAS) PT Raised to $20 at H.C. Wainwright
Mar 10, 2026 03:09PM Erasca, Inc (ERAS) 3500 contracts of December 15 calls trade
Mar 10, 2026 02:36PM Erasca Inc (ERAS) PT Raised to $20 at Stifel
Mar 10, 2026 08:03AM Erasca expands ERAS-0015 license to secure worldwide rights
Mar 5, 2026 05:16PM Erasca Inc (ERAS) PT Raised to $20 at Clear Street
Feb 9, 2026 07:29AM Erasca (ERAS) Reiterated at Buy by Stifel: Chinese 'me too Assets' Unlikely
Jan 27, 2026 07:11AM Erasca Inc (ERAS) PT Raised to $12 at Guggenheim
Jan 27, 2026 01:06AM Mizuho Assumes Erasca Inc (ERAS) at Outperform
Jan 26, 2026 06:47AM Erasca Inc (ERAS) PT Raised to $15 at H.C. Wainwright
Jan 13, 2026 06:40AM Erasca Inc (ERAS) PT Raised to $11 at H.C. Wainwright
Jan 12, 2026 12:12PM Erasca Inc (ERAS) PT Raised to $10 at Stifel
Jan 12, 2026 08:03AM Erasca reports early clinical responses for cancer drug ERAS-0015
Jan 7, 2026 12:28PM Oppenheimer on BridgeBio Oncology Therapeutics, In (BBOT): 'We think the lack of idiosyncratic toxicity is particularly notable for BBO-10203'
Jan 7, 2026 12:11PM Erasca, Inc (ERAS) Pulls Back from 20+pct Jump, Stifel: 'Today's Strength Driven by Competitor Readthrough'
Jan 7, 2026 03:45AM Piper Sandler Starts Erasca Inc (ERAS) at Overweight
Dec 9, 2025 07:18AM Erasca Inc (ERAS) PT Raised to $5 at Mizuho
Nov 14, 2025 06:33AM Erasca Inc (ERAS) PT Raised to $5 at Guggenheim
Nov 13, 2025 09:39AM Stifel Reiterates Buy Rating on Erasca Inc (ERAS) Following Q3 Results
Nov 6, 2025 08:06AM Erasca receives US patent for pan-RAS molecular glue ERAS-0015
Oct 15, 2025 04:09PM Stifel Starts Erasca Inc (ERAS) at Buy
Sep 3, 2025 06:10AM BofA Securities Double Downgrades Erasca Inc (ERAS) to Underperform
Aug 18, 2025 03:38AM Morgan Stanley Downgrades Erasca Inc (ERAS) to Equalweight
View Older Stories